MetLife Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

MetLife Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.87M	Sell	9,300 -937	-9%	-$448K	0.02%	623
2025 Q4	$5.96M	Sell	10,237 -570	-5%	-$291K	0.03%	547
2025 Q3	$4.96M	Buy	10,807 +745	+7%	+$278K	0.02%	637
2025 Q2	$3.05M	Sell	10,062 -391	-4%	-$116K	0.02%	790
2025 Q1	$3.46M	Sell	10,453 -365	-3%	-$120K	0.02%	796
2024 Q4	$3.34M	Buy	10,818 +695	+7%	+$195K	0.02%	782
2024 Q3	$2.15M	Hold	10,123	–	–	0.01%	982
2024 Q2	$2.84M	Buy	10,123 +2,537	+33%	+$604K	0.02%	811
2024 Q1	$2.03M	Sell	7,586 -172	-2%	-$40.5K	0.01%	942
2023 Q4	$1.8M	Buy	7,758 +581	+8%	+$102K	0.01%	988
2023 Q3	$1.05M	Hold	7,177	–	–	0.01%	1204
2023 Q2	$1.66M	Buy	7,177 +495	+7%	+$134K	0.01%	1007
2023 Q1	$1.62M	Hold	6,682	–	–	0.01%	991
2022 Q4	$1.94M	Hold	6,682	–	–	0.01%	920
2022 Q3	$434K	Hold	6,682	–	–	﹤0.01%	1743
2022 Q2	$478K	Hold	6,682	–	–	﹤0.01%	1700
2022 Q1	$656K	Buy	6,682 +2,468	+59%	+$208K	﹤0.01%	1610
2021 Q4	$357K	Buy	4,214 +527	+14%	+$43.3K	﹤0.01%	1693
2021 Q3	$294K	Hold	3,687	–	–	﹤0.01%	1831
2021 Q2	$359K	Hold	3,687	–	–	﹤0.01%	1776
2021 Q1	$431K	Hold	3,687	–	–	﹤0.01%	1616
2020 Q4	$410K	Hold	3,687	–	–	﹤0.01%	1586
2020 Q3	$438K	Hold	3,687	–	–	﹤0.01%	1434
2020 Q2	$418K	Hold	3,687	–	–	﹤0.01%	1484
2020 Q1	$246K	Hold	3,687	–	–	﹤0.01%	1580
2019 Q4	$336K	Hold	3,687	–	–	﹤0.01%	1672
2019 Q3	$318K	Hold	3,687	–	–	﹤0.01%	1676
2019 Q2	$386K	Buy	3,687 +564	+18%	+$60.4K	﹤0.01%	1630
2019 Q1	$391K	Hold	3,123	–	–	﹤0.01%	1600
2018 Q4	$352K	Hold	3,123	–	–	﹤0.01%	1582
2018 Q3	$669K	Buy	3,123 +422	+16%	+$106K	0.01%	1349
2018 Q2	$755K	Buy	2,701 +586	+28%	+$103K	0.01%	1164
2018 Q1	$247K	Hold	2,115	–	–	﹤0.01%	1774
2017 Q4	$194K	Buy	+2,115	New	+$121K	﹤0.01%	1943